Ligand id: 5082

Name: trastuzumab

IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: trastuzumab

1. Dokter W, Ubink R, van der Lee M, van der Vleuten M, van Achterberg T, Jacobs D, Loosveld E, van den Dobbelsteen D, Egging D, Mattaar E et al.. (2014)
Preclinical profile of the HER2-targeting ADC SYD983/SYD985: introduction of a new duocarmycin-based linker-drug platform.
Mol. Cancer Ther.13 (11): 2618-29. [PMID:25189543]
2. Hudziak RM, Shepard HM, Ullrich A. (1989)
Method of treating tumor cells by inhibiting growth factor receptor function.
Patent number: WO1989006692. Assignee: Genentech Inc. Priority date: 12/01/1988. Publication date: 27/07/1989.